Regis Healthcare (REG) H1 2025 earnings summary

Executive summary

• Revenue from services rose to AUD 564.2 million for H1 FY25, up 18% year-over-year, driven by higher occupancy, government funding, and acquisitions.

• Underlying EBITDA increased 31% to AUD 68.1 million, and net profit after tax surged 301% to AUD 24.4 million, reversing a prior year loss.

• Net operating cash flow grew 37% to AUD 208.6 million, with net cash position at AUD 179.9 million.

• Interim dividend of 8.09 cents per share (60% franked), representing 100% of NPAT, was declared.

• Strategic focus on expanding residential aged care footprint, enhancing service offerings, and leveraging technology for operational efficiency.

Financial highlights

• Underlying EBIT surged 523% to AUD 44.4 million; underlying EBITDA margin improved to 12.1%.

• Net RAD cash inflow doubled to AUD 85.8 million; capital expenditure was AUD 32.7 million, focused on development and refurbishment.

• Staff expenses/revenue from services improved to 75.4%, down from 76.3% year-over-year.

• Basic EPS was 8.09 cents, up from a loss of 4.03 cents per share in H1 FY24.

• Net operating cash flow was AUD 208.6 million, up 37% year-over-year.

Outlook and guidance

• Expects continued high occupancy (96%+) in mature homes and benefits from new Aged Care Act and increased government funding.

• CapEx for the full year projected at AUD 35–40 million, reflecting ongoing refurbishments and developments.

• Plans to leverage strong balance sheet and undrawn debt facilities for further acquisitions and greenfield developments.

• Anticipates growth from demographic trends, sector reforms, and improved workforce availability.